Sabatini Brent (CIK 2037272) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-02). Recent activity: Sell VIR (379 shares), Sell VIR (7,711 shares), Sell VIR (1,430 shares), Buy VIR (25,000 shares), Sell VIR (1,829 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-02 | Vir Biotechnology, Inc. (VIR) | SVP, Chief Accounting Officer | Sell | 379 | $3,582 |
| 2026-03-24 | Vir Biotechnology, Inc. (VIR) | SVP, Chief Accounting Officer | Sell | 7,711 | $70,324 |
| 2026-02-26 | Vir Biotechnology, Inc. (VIR) | SVP, Chief Accounting Officer | Sell | 1,430 | $13,628 |
| 2026-02-24 | Vir Biotechnology, Inc. (VIR) | SVP, Chief Accounting Officer | Buy | 25,000 | $0 |
| 2026-02-24 | Vir Biotechnology, Inc. (VIR) | SVP, Chief Accounting Officer | Sell | 1,829 | $13,626 |
| 2026-02-18 | Vir Biotechnology, Inc. (VIR) | SVP, Chief Accounting Officer | Sell | 1,530 | $11,919 |
| 2025-02-25 | Vir Biotechnology, Inc. (VIR) | SVP, Chief Accounting Officer | Buy | 20,000 | $0 |
| 2025-02-25 | Vir Biotechnology, Inc. (VIR) | SVP, Chief Accounting Officer | Sell | 1,562 | $14,761 |
| 2025-02-14 | Vir Biotechnology, Inc. (VIR) | SVP, Chief Accounting Officer | Sell | 1,562 | $14,292 |
Source: SEC Form 4 filings · as of 2026-06-02